Entity Common Stock, Shares Outstanding of ABVC BIOPHARMA, INC. from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Abvc Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • Abvc Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Oct 2025 was 24.3M shares, a 87.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 24.3M +11.3M +87.3% 30 Oct 2025 10-Q 03 Nov 2025
Q2 2025 23.5M +11.1M +89.5% 12 Aug 2025 10-Q 13 Aug 2025
Q1 2025 15.8M +5.22M +49.4% 11 Apr 2025 10-K 15 Apr 2025
Q3 2024 13M +5.74M +79.4% 13 Nov 2024 10-Q 14 Nov 2024
Q2 2024 12.4M +8.47M +214% 14 Aug 2024 10-Q 14 Aug 2024
Q1 2024 10.6M -22.5M -68.1% 12 Mar 2024 10-K/A 15 Mar 2024
Q3 2023 7.23M -25.4M -77.8% 09 Nov 2023 10-Q 15 Nov 2023
Q2 2023 3.95M -28.7M -87.9% 09 Aug 2023 10-Q 14 Aug 2023
Q1 2023 33.1M +2.77M +9.15% 31 Mar 2023 10-K 31 Mar 2023
Q3 2022 32.6M +4.02M +14.1% 11 Nov 2022 10-Q 14 Nov 2022
Q2 2022 32.6M +8.16M +33.4% 10 Aug 2022 10-Q 15 Aug 2022
Q1 2022 30.3M +5.89M +24.1% 30 Mar 2022 10-K/A 06 Jun 2022
Q3 2021 28.6M +7.8M +37.5% 12 Nov 2021 10-Q 15 Nov 2021
Q2 2021 24.5M +4.98M +25.6% 11 Aug 2021 10-Q 12 Aug 2021
Q1 2021 24.4M +4.93M +25.3% 15 Mar 2021 10-K 16 Mar 2021
Q3 2020 20.8M 12 Nov 2020 10-Q 17 Nov 2020
Q2 2020 19.5M +1.37M +7.53% 26 Jun 2020 10-Q 29 Jun 2020
Q1 2020 19.5M -194M -90.9% 11 May 2020 10-K 15 May 2020
Q4 2019 19.5M 15 Nov 2019 10-Q 18 Nov 2019
Q2 2019 18.1M 07 Aug 2019 10-Q 09 Aug 2019
Q1 2019 214M 0 0% 08 Apr 2019 10-K 15 Apr 2019
Q3 2018 214M +180K +0.08% 13 Nov 2018 10-Q 14 Nov 2018
Q1 2018 214M 28 Mar 2018 10-KT 13 Apr 2018
Q3 2017 214M 18 Aug 2017 10-Q 19 Mar 2018
Q2 2017 214M +4.39M +2.1% 19 May 2017 10-Q/A 19 Mar 2018
Q4 2016 211M +151M +251% 06 Jan 2017 10-K/A 22 Sep 2017
Q2 2016 209M +155M +283% 10 Aug 2016 10-Q 22 Feb 2017
Q1 2016 66.4M +11.8M +21.7% 18 Feb 2016 10-Q 23 Feb 2016
Q4 2015 60M +5.42M +9.93% 25 Nov 2015 10-K 27 Nov 2015
Q2 2015 54.6M 31 Jul 2015 10-Q 19 Aug 2015
Q1 2015 54.6M 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 54.6M 31 Dec 2014 10-Q 17 Apr 2015
Q4 2012 54.6M +38.3M +234% 31 Dec 2012 10-Q 16 Apr 2015
Q2 2012 54.5M +43.9M +412% 30 Jun 2012 10-Q/A 20 Aug 2012
Q4 2011 16.3M 31 Jan 2012 10-Q 21 Feb 2012
Q2 2011 10.7M 15 Jul 2011 10-Q/A 08 Sep 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.